Prospect of ginseng under the pharmaceutical industry in Angel in 2020

Affected by the policy of "returning farmland to forests" and the growing period, ginseng resources under forests are scarce. Since 20 14, the company has made a strategic reserve of ginseng resources under the forest. When china securities journal visited a ginseng planting base of Angel Pharmaceutical in Changbai Mountain, it happened that the company was excavating 50,000 ginseng plants that had grown for 10 years. These undergrowth ginseng will be sold all over the country in the form of fresh ginseng. Guo Chunlin, chairman of Angel Pharmaceutical Company, told the reporter that starting from this year, ginseng under the forest of the company will gradually enter the harvest period. These resources are changing from strategic reserve to benefit harvest.

Guo Chunlin said that the price of ginseng has fluctuated greatly in recent years, mainly because the quality of ginseng is uneven, but high-end and high-quality ginseng is still a hot commodity. The dry ginseng stored by the company is all products of 5 years and above, and the key strategic reserve is forest ginseng.

Senior forestry experts told reporters that ginseng under the forest has a long growth cycle, large investment and slow effect. Due to less human intervention, ginseng has high added value and good economic benefits.

"It is precisely because of the preciousness and scarcity of ginseng under the forest that a large number of plants, acquisitions and storage are carried out, strategic layout is carried out, resource control ability is improved, the supply of high-quality ginseng raw materials is guaranteed, and the terminal consumption market of ginseng products is better developed." Guo Chunlin said.

According to the relevant planning of Angel Pharmaceutical, by 2022, the total ginseng planting area of the company will increase to about 5 million square meters. Among them, the yield of ginseng under the forest is about 36.36 million in six years, 32.84 million in July-12, and 2.9 million in June -05- 16. The raw rate of ginseng is over 90%, and the number of ginseng planting bases has increased to about 30.

Market participants said that the scarcity of ginseng resources under the forest provided strong support for its price. With the gradual improvement of higher value-added industrial chain, high-end ginseng represented by Linxia ginseng is more favored by the market and has strong liquidity.

"The development of ginseng industry will become more and more standardized, and the standards of downstream drugs and food will become more and more strict." Guo Chunlin said, "Low-end seeds that do not meet the standard requirements are facing an increasingly severe situation, and high-end seeds have a broad market space."

For the daily maintenance of the forest, "even a little human intervention will be reflected in the appearance." The relevant person in charge of the Ginseng Division of Angel Pharmaceutical Co., Ltd. said, "Wild boar, rats and badgers often appear in mountainous areas. In addition to observing the growth of ginseng, the daily inspection focuses on preventing wild animals from harassing and creating a good environment for the growth of ginseng under the forest. "

During the visit of china securities journal reporter to Linxia ginseng planting base, it happened that the company excavated 50,000 Linxia ginseng plants 10 year. These undergrowth ginseng will be mainly sold as fresh products, and the pre-sale has been completed at 20 million yuan. Among them,150,000 yuan was pre-sold through the sales network of specialty stores, online sales platforms and channel agents, and 5 million yuan was pre-sold through the national pharmaceutical chain terminal team.

In addition, the company also excavated 1.5-year-old ginseng plants 1.5 million in Ma Xian Township, Ji 'an City, and processed them into sun-dried products for sale. The estimated operating income is about 80 million yuan. These sales have been incorporated into the company.